EIM
ONC

Essex Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Essex Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,896
Closed -$1.53M – 516
2018
Q4 		$1.53M Buy
10,896
+7,443
+216% +$987K 0.24% 130
2018
Q3 		$595K Buy
+3,453
New +$581K 0.07% 286

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Essex Investment Management's ONC Position: Q1 2019 in Review

Essex Investment Management sold out of BeOne Medicines Ltd (ONC) in Q1 2019, closing a stake of 10,896 shares — an estimated $1.53M sold.

Essex Investment Management first reported a position in ONC in Q3 2018 and held it in 2 quarters. The position peaked at $1.53M in Q4 2018. 199 funds tracked by Wall St. Rank hold ONC as of Q1 2019.

  • Essex Investment Management reported no remaining BeOne Medicines Ltd position as of Q1 2019 after selling out during the quarter.
  • Essex Investment Management sold 10,896 BeOne Medicines Ltd shares in Q1 2019, an estimated $1.53M.
  • Essex Investment Management first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 2 quarters.
  • Essex Investment Management's BeOne Medicines Ltd position peaked at $1.53M in Q4 2018.
  • 199 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2019.

Based on Essex Investment Management's 13F filing for Q1 2019, filed 15 May 2019.